iNephrology: The Next Frontier

The purpose of this activity is to enable the learner to better understand how health information technology can be used to enhance the delivery of nephrology care. In particular, learners will hear about: how health IT enables self-management support for patients with chronic disease, including CKD; the potential pitfalls of using health information technology for self-management among low-income, racially/ethnically diverse patient populations; and the increased reach that tele-nephrology can afford kidney specialists. 

Target Audience

  • Physician
  • Transplant Professionals
Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; complete the pre-test; complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit. The estimated time for completion is 1.5 hours. To receive AMA PRA Category 1 Credit(s)™, participants must receive a minimum score of 70% on the post-test.   

If you participated in the live symposium iNephrology: The Next Frontier on Thursday, April 20, 2017 and claimed credit, you should not claim credit for this endured activity.

Learning Objectives

After participation in this activity, learners will be better able to:

  • Discuss examples of health technology that have been shown to increase patient engagement in nephrology care
  • Identify challenges associated with mobile health technology for delivery of nephrology care to minority populations
  • Describe how telenephrology can enhance access to specialty care
Course summary
Available credit: 
  • 1.50 ABTC Continuing Education Points
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
11/06/2017
Course expires: 
11/15/2019
Cost:
$35.00
Rating: 
0
Faculty Disclosures:

Stephanie Ong, BScPHM, MSc
Clinical Pharmacist
University Health Network
Toronto, ON
Disclosure: Has no financial relationships with commercial interest(s).

Clarissa Diamantidis, MD, MHS
Assistant Professor of Medicine
Duke University
Durham, NC
Disclosure: Has no financial relationships with commercial interest(s).

Eric Wallace, MD
Assistant Professor of Medicine
University of Alabama at Birmingham
Birmingham, AL
Disclosure: The speaker received consulting fees, industry sponsored grant from SanofiGenzyme in the subject of Fabry Disease, consulting fees from Baxter Healthcare Corp in the subject of Peritoneal Dialysis and Telemedicine

Planning Committee Disclosures:

Delphine Tuot, MDCM, MAS
Assistant Professor of Medicine
University of California San Francisco & Zuckerberg San Francisco General Hospital
San Francisco, CA
Disclosure: Has no financial relationships with commercial interest(s).

Carolyn Atkins, BS, RN, CCTC, FNKF
Nephrology Consultant
Dallas, TX
Disclosure: Has no financial relationships with commercial interest(s).

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this online CME/CE for a maximum of 1.5 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Transplant Professionals

The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 1.5 Category I Continuing Education Points for Transplant Certification (CEPTCs). 

Available Credit

  • 1.50 ABTC Continuing Education Points
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Accreditation Period

Course opens: 
11/06/2017
Course expires: 
11/15/2019

Price

Cost:
$35.00
Please login or register for a PERC account to take this course.
Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals